As we enter a period of budgetary contraction and debate over military spending, and consider the remarkable humanitarian contributions of the U.S. Navy in the Pacific, the Americas, Africa, and elsewhere, the time is ripe for a thoughtful, analytic, and nonpartisan study of American naval medical diplomacy, with strategic and realistic recommendations for its future.
On June 4, CSIS launched an independent task force of experts, chaired by former Chief of Naval Operations Admiral Gary Roughead, to study the value of the U.S. Navy’s proactive humanitarian assistance; to examine the Navy’s capacity for such missions in the future; to review the history and evolution of policy and programs in this area; to forecast the demands on military medicine and humanitarian missions in an age of new technologies and evolving threats to global health; and to inform a sensible, long-term strategy for naval medical diplomacy going forward.
The June 4 event provided a brief explanation of the genesis, purpose, work plan, and expected products of this CSIS task force. We then turned to a lively roundtable discussion, led by Dr. John Hamre, that will put a spotlight on the U.S. Navy's soft power tools and the evolving importance of its humanitarian missions as U.S. foreign policy pivots toward Asia and the Pacific.
Another Candidate HIV Vaccine Fails: We Must Keep Trying Yesterday, the National Institute for Allergy and Infectious Diseases (NIAID) of the U.S. National Institutes of Health (NIH) announced that it was stopping further testing of a candidate HIV vaccine combination (study HVTN 505). While this is a disappointing turn of events, perseverance is needed.
President’s Malaria Initiative: Big Success from a Quiet Team While the giant PEPFAR program to fight HIV/AIDS in developing countries gets a lot of attention in U.S. foreign policy discussions, a lesser known initiative to address malaria is achieving sustained, impressive results: The President’s Malaria Initiative (PMI).
Global TB Control Through Partnerships On March 21, KNCV honored USAID for the agency’s contribution to the field of global TB control. Dr. Sharon Stash spoke at the awards ceremony and noted options for how the U.S. government can advance these global efforts.
New Institute of Medicine Report on Illegitimate Drugs: A Moral Tragedy The IOM recently released a new report on Countering the Problem of Falsified and Substandard Drugs. It raises important, indeed frightening, concerns about the quality and reliability of medicines in the U.S. and other developed nations, as well as in low- and middle-income countries, and proposes concrete steps in response.